Nivolumab monotherapy after induction chemotherapy, bioradiotherapy, and cetuximab monotherapy leading to complete remission of locoregional advanced tongue cancer: A case report

被引：3
|
作者：
Yoshioka, Yukio [1 ]
Hamana, Tomoaki [1 ]
Mishima, Takefumi [2 ]
Tani, Ryouji [2 ]
Toratani, Shigeaki [1 ]
Okamoto, Tetsuji [1 ,3 ]
机构：
[1] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Mol Oral Med & Maxillofacial Surg, Hiroshima, Japan
[2] Hiroshima Univ Hosp, Dept Oral & Maxillofacial Surg, Hiroshima, Japan
[3] Univ East Asia, Sch Med Sci, Shimonoseki, Yamaguchi, Japan
来源：
ORAL SCIENCE INTERNATIONAL | 2022年 / 19卷 / 01期
关键词：
Cetuximab; induction chemotherapy; nivolumab; tongue neoplasms; SQUAMOUS-CELL CARCINOMA; HEAD; RECURRENT;
D O I：
10.1002/osi2.1114
中图分类号：
R78 [口腔科学];
学科分类号：
1003 ;
摘要：
Herein, we report on a 66-year-old woman with locoregional advanced tongue cancer. She was diagnosed with left side tongue carcinoma and achieved complete remission using nivolumab monotherapy after induction chemotherapy (IC) with docetaxel, cisplatin, and 5-fluorouracil, followed by intensity-modulated bioradiotherapy and cetuximab monotherapy. Following bioradiotherapy, she was administered 70 cycles of cetuximab monotherapy. Both IC and bioradiotherapy exerted antitumor effects. However, primary tumor recurrence occurred. She received nivolumab, and the recurrent lesion disappeared after 18 cycles. She has been alive and well for >5 years, showing a successful locoregional control for advanced tongue cancer during this period.
引用
收藏
页码：72 / 76
页数：5
相关论文
共 50 条
  • [31] Nivolumab plus gemcitabine, dexamethasone, and cisplatin chemotherapy induce durable complete remission in relapsed/refractory primary mediastinal B-cell lymphoma: a case report and literature review
    Huang, Gang
    Huang, Ju
    Zhang, Zhili
    Xue, Chongchong
    Liu, Yuan
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (08)
  • [32] Repeating late-phase pseudo-progression in a patient with non-small cell lung cancer treated with long-term nivolumab monotherapy; a case report
    Ebisuda, Rikako
    Furuya, Naoki
    Inoue, Takeo
    Kaneko, Shotaro
    Numata, Yu
    Shinozaki, Yusuke
    Mineshita, Masamichi
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [33] Case report: A rare case of acute hemolysis in advanced rectal cancer after XELOX and nivolumab treatment: analysis of drug-dependent antibodies
    Zhao, Dengke
    Song, Qiao
    Wu, Chunyan
    Wang, Shuye
    FRONTIERS IN MEDICINE, 2023, 10
  • [34] Bile duct obstruction in a patient treated with nivolumab as second-line chemotherapy for advanced non-small-cell lung cancer: a case report
    Jumpei Kashima
    Yusuke Okuma
    Ryoko Shimizuguchi
    Kazuro Chiba
    Cancer Immunology, Immunotherapy, 2018, 67 : 61 - 65
  • [35] Bile duct obstruction in a patient treated with nivolumab as second-line chemotherapy for advanced non-small-cell lung cancer: a case report
    Kashima, Jumpei
    Okuma, Yusuke
    Shimizuguchi, Ryoko
    Chiba, Kazuro
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (01) : 61 - 65
  • [36] An Early-Onset Advanced Rectal Cancer Patient With Increased KRAS Gene Copy Number Showed A Primary Resistance to Cetuximab in Combination With Chemotherapy: A Case Report
    Fang, Tian
    Liang, Tingting
    Wang, Yizhuo
    Wu, Haitao
    Liu, Shuhan
    Xie, Linying
    Zhang, Zhihao
    Liang, Jiaying
    Yao, Cheng
    Tan, Yehui
    Wang, Chang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [37] Drastic healing process after pembrolizumab monotherapy in a case of advanced squamous cell carcinoma with severe bronchial stenosis observed over a two-year period using continuous bronchoscopy: A case report
    Morikawa, Kei
    Kida, Hirotaka
    Handa, Hiroshi
    Inoue, Takeo
    Miyazawa, Teruomi
    Mineshita, Masamichi
    THORACIC CANCER, 2020, 11 (05) : 1339 - 1343
  • [38] Portal vein thrombosis after cetuximab and 5-fluorouracil therapy in a patient with advanced colon cancer and decompensated cirrhosis: a case report and review of the literature
    Fangyu Liu
    Yongmei Xu
    Guowang Yang
    Yuhong Guo
    Jiayun Nian
    World Journal of Surgical Oncology, 21
  • [39] Portal vein thrombosis after cetuximab and 5-fluorouracil therapy in a patient with advanced colon cancer and decompensated cirrhosis: a case report and review of the literature
    Liu, Fangyu
    Xu, Yongmei
    Yang, Guowang
    Guo, Yuhong
    Nian, Jiayun
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [40] Satisfactory short-term outcome after anlotinib and docetaxel chemotherapy in tongue cancer with N3 cervical lymph node metastasis: A case report
    Deng, Yi
    Zhong, Zhao-Yang
    Tan, Xiao-Rong
    Wang, Shuai
    Qian, Kai
    CLINICAL CASE REPORTS, 2019, 7 (10): : 1923 - 1927
12345